Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
J. Clin. Invest. Victoria Del Gaizo Moore, et al. 117:112
doi:10.1172/JCI28281 [Go to this article.]

Problems with a PDF?